Drug Database
Back to search

Czechia· CZ-0242230

CYTARABINE ACCORD

A cytarabine product containing cytarabine, registered in Czechia by ACCORD HEALTHCARE POLSKA Sp. z o.o., Varšava. The same ATC class is registered in 16 of our 19 countries.

ATC L01BC01

Checked against SÚKL (Czech Republic) on

Informational only — not a medical device.

SOURCE REGISTER · CZSÚKL (Czech Republic)normalisedCYTARABINE ACCORDATCL01BC01REGISTER NO.CZ-0242230PACKS LISTED0CHECKEDSeptember 28, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about cytarabineAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Cytarabine is registered in 16 of 19 countries.

Countries holding a registration under ATC L01BC01 (cytarabine), each read from that country’s own register.

  • This record: Czechia, from SÚKL (Czech Republic)
  • 9 of them publish a price we can compare per daily dose
Search cytarabine products by name

Cytarabine · ATC L01BC01

16 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Franceprice
  • Germany
  • Icelandprice
  • Ireland
  • Netherlands
  • Norwayprice
  • Polandprice
  • Sweden
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

SÚKL (Czech Republic)
Active substance
CYTARABINE
Manufacturer
ACCORD HEALTHCARE POLSKA Sp. z o.o., Varšava
Country
Czechia (CZ)
ATC code
L01BC01
ATC class
Cytarabine
Reimbursed
Not published by this register
Source register
SÚKL (Czech Republic)
Last checked
September 28, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

415 interactions on record for cytarabine.

Graded by severity as the source publishes them — 35 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check cytarabine against other medicinesHow interaction checks work

Cytarabine · interactions on record

415 records

  • 35 severe
  • 113 moderate
  • 16 minor
  • 251 info

Most severe, free to view

  • MipomersenC10AX11severe
  • LomitapideC10AX12severe
  • CladribineL01BB04severe
  • PexidartinibL01EX15severe
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Cytarabine in 15 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All cytarabine products

Authorised across Europe · EMA

The same active substance is authorised in 29 EEA countries. Names it is sold under:

  • Austria · Alexan, Cytarabin Accord
  • Belgium · Cytarabine Accord Healthcare, Cytarabine Fresenius Kabi
  • Bulgaria · Алексан, Цитарабин Акорд
  • Cyprus · Cytarabine Accord, Cytarabine Pfizer Hellas
  • Germany · Ara-Cell, Cytarabin Accord
  • Denmark · Cytarabin Fresenius Kabi, Cytarabine Accord
  • Estonia · Cytarabine Accord, Cytarabine Kabi
  • Spain · Citarabina Accord, Citarabina Kabi
  • Finland · Cytarabine Accord, Cytarabine Accord Healthcare
  • France · Aracytine, Cytarabine Accord
  • United Kingdom (Northern Ireland) · Cytarabine Accord Healthcare, Cytarabine Fresenius Kabi Oncology
  • Greece · Aracytin, Citabion
  • Croatia · Cytosar
  • Hungary · Alexan, Cytarabine Accord
  • Ireland · Cytarabine, Cytarabine Accord Healthcare Ireland
  • Iceland · Cytarabin Fresenius Kabi, Cytarabine Pfizer
  • Italy · Aracytin, Citarabina Accord
  • Lithuania · Cytarabine Accord, Cytarabine Kabi
  • Luxembourg · Cytosar
  • Latvia · Cytarabine Accord, Cytarabine Kabi
  • Malta · Cytarabine Accord Healthcare, Cytarabine Pfizer Hellas
  • Netherlands · Cytarabine Accord, Cytarabine Fresenius Kabi
  • Norway · Cytarabin Fresenius Kabi, Cytarabine Accord
  • Poland · Alexan, Cytarabina Accord
  • Portugal · Citaloxan, Citarabina Accord
  • Romania · Citarabină Accord, Citarabina Kabi
  • Sweden · Cytarabin Fresenius Kabi, Cytarabin Hikma
  • Slovenia · Citarabin Accord, Cytosar
  • Slovakia · Cytarabine Accord, Cytosar

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of SÚKL (Czech Republic). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/df498f2f-90c2-41dc-ac58-6fc954fc6459
GET /v1/drugs/df498f2f-90c2-41dc-ac58-6fc954fc6459?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "INJ/INF SOL",
  "source": "sukl",
  "strength": "100MG/ML",
  "pack_size": "1X40ML",
  "substance": "CYTARABINE",
  "cz_kod_sukl": "0242230",
  "product_type": "CH",
  "substance_codes": "1570",
  "registration_state": "R",
  "registration_number": "44/409/13-C"
}
API referenceMCP serverPlans

See everything about cytarabine.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console